-
Company Insights
![]()
Innovation and Patenting activity of Anora Group Plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Anora Group Plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Profile
New![]()
Anora Group Plc – Company Profile
Anora Group Plc (Anora) is a manufacturer of alcoholic beverages. The company produces, markets, sells, imports and exports beverages including vodka, gin, wines, cognac, beer and spirits. It also offers technical ethanol, feed components and starch. Anora markets its products under the brands Koskenkorva, LINIE, O.P. Anderson, Larsen, Skagerrak, Chill Out, Ruby Zin, Blossa, Wongraven, and Falling Feather. The company offers its products to retail monopolies, alcoholic beverage wholesale outlets, restaurants, grocery stores, travel trade and importers. It has distilleries...
Add to Basket -
Company Profile
![]()
Natera Inc – Company Profile
Natera Inc (Natera) develops genetic and cell-free deoxyribonucleic acid (cfDNA) testing solutions. The company’s products include Signatera, a personalized ctDNA (circulating tumor DNA) blood test to assess MRD (molecular residual disease) and its recurrence; Aletra, a tissue-based genomic profiling test to identify genomic alterations and oncology biomarkers in a tumor; Prospera, a transplant rejection test to evaluate the risk of rejection of a transplanted kidney. It also offers Renasight test to detect genetic cause of kidney diseases, Horizon carrier screening...
Add to Basket -
Product Insights
New![]()
Natera Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Natera Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Natera Inc (Natera), formerly Gene Security Network LLC, develops genetic and cell-free deoxyribonucleic acid (cfDNA) testing solutions. The company’s products include Signatera, a personalized ctDNA (circulating tumor DNA) blood test to assess MRD (molecular residual disease) and its recurrence; Aletra, a tissue-based genomic profiling test to identify genomic alterations and oncology biomarkers in a tumor; Prospera, a transplant rejection test...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.